Blood dendritic cells are decreased in acute graft-versus-host disease

Bone Marrow Transplantation

Volumn 33, Issue 10, 2004, Pages 989-996

  Takebayashi, M ^a   Amakawa, R ^a   Tajima, K ^a   Miyaji, M ^a   Nakamura, K ^a   Ito, T ^a   Matsumoto, N ^a   Miyazaki, Y ^a   Zen, K ^a   Kishimoto, Y ^a   Fukuhara, S ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute graft versus host disease; Allogeneic hematopoietic stem cell transplantation; Dendritic cells

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FASCIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL COUNT; CELL INFILTRATION; CELL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MALE; PRIORITY JOURNAL; RECIPIENT; SKIN BIOPSY; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIOPSY; CARRIER PROTEINS; CULTURE MEDIA; DENDRITIC CELLS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MYELOID CELLS; SKIN; TIME FACTORS;

EID: 2942565766     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704406     Document Type: Article

References (30)

1. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895-902.
2. Roy J, McGlave PB, Filipovich AH et al. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant 1992; 10: 77-82.
3. Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 1985; 88: 215-238.
4. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
5. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964-2968.
6. Ferrara JL. The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant 1998; 21 (Suppl. 3): S13-S15.
7. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
9. Inaba K, Metlay JP, Crowley MT et al. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990; 172: 631-640.
10. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets: isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994; 153: 4016-4028.
11. Robinson SP, Patterson S, English N et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769-2778.
12. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-1186.
13. Siegal FP, Kadowaki N, Shodell M et al. The nature of principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835-1837.
14. Ozaki Y, Amakawa R, Ito T et al. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum 2001; 44: 419-431.
15. Uehira K, Amakawa R, Ito T et al. Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 2002; 105: 296-303.
16. Blanco P, Palucka AK, Gill M et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
17. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
18. Ito T, Inaba M, Inaba K et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999; 163: 1409-1419.
19. Fithian E, Kung P, Goldstein G et al. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 2541-2544.
20. Emile JF, Fraitag S, Leborgne M et al. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol 1994; 174: 71-76.
21. Ross R, Ross XL, Schwing J et al. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epiderminal Langerhans cells. J Immunol 1998; 15: 3776-3782.
22. Al-Alwan MM, Rowden G, Lee TD et al. Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 2001; 166: 338-345.
23. Matyszak MK, Citterio S, Rescigno M et al. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 2000; 30: 1233-1242.
24. Pan J, Ju D, Wang Q et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001; 76: 153-161.
25. Suitters AJ, Lampert IA. The loss of Ia+ Langerhans' cells during graft-versus-host disease in rats. Transplantation 1983; 36: 540-546.
26. Perreault C, Pelletier M, Landry D et al. Study of Langerhans cells after allogeneic bone marrow transplantation. Blood 1984; 63: 807-811.
27. Deguchi M, Aiba S, Ohtani H et al. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses. Arch Dermatol Res 2002; 294: 297-302.
28. Riedl E, Stockl J, Majdic O et al. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 2000; 96: 4276-4284.
29. Shlomchic WD, Couzens MS, Tang CB et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412-415.
30. Zhang Y, Shlomchik WD, Joe G et al. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol 2002; 169: 7111-7118.